Discrimination on synthesized drugs over biologics in drug pricing

It was criticized synthesized drugs have been discriminated also in drug pricing due to supports leaning only on the biotech field.

A source from the pharmaceutical industry reported there were different drug pricing standards between biobetters and incrementally modified drugs in the ‘Medicine Decision and Adjustment Standards’ officially noticed on the last 4^th of May by the Ministry of Heal...